Feasibility of Using Ceftazidime-Avibactam as a Therapeutic Option for Bloodstream Infections Caused by Multidrug-Resistant Enterobacterales and Pseudomonas aeruginosa Based on Its Susceptibility Profile

Background In the era of increased antimicrobial resistance, there are limited therapeutic options available for the treatment of bacteremia caused by multidrug-resistant organisms (MDROs). This study aims to find out the feasibility of using ceftazidime/avibactam (CZA) as a therapeutic option for b...

Descripción completa

Detalles Bibliográficos
Autores principales: Priyadarshi, Ketan, Dhandapani, Sarumathi, Sivaradjy, Monika, Shanmugam, Lakshmi, Sastry, Apurba S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151155/
https://www.ncbi.nlm.nih.gov/pubmed/37139019
http://dx.doi.org/10.7759/cureus.37002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151155/
https://www.ncbi.nlm.nih.gov/pubmed/37139019
http://dx.doi.org/10.7759/cureus.37002

Ejemplares similares